Genmab — Juli 2020
-
God morgen.
-
Genmab på rekordkurs får sat kursmål op af Barclays
07:16
Gen
mab, der i disse dage sætter den ene rekord efter den anden for aktiekursen, får hævet kursmålet af Barclays til 2400 kr. fra 2250 kr.Det fremgår af data fra Bloomberg News.
I samme runde fastholdes anbefalingen overvægt.
En aktie i Genmab steg torsdag med 1,5 pct. til 2334 kr., hvilket var endnu en rekord.
/ritzau/FINANS
-
Tak Klarussen.:-)
-
Vi mangler bare fuksvansen før alt er som det plejer at være. Men ok..selv robotter skal have lidt sommerferie.
-
Du har kaldt den slags før. Jeg satser på at du får ret igen i dag. Så kommer der vin på bordet hos vore chatdeltagere ude i teltet, campingvognen eller i sommerhuset.
-
#FDA: The ocular toxicity associated with treatment with belantamab mafodotin is a major safety concern. The mechanism is not completely understood, and this is a novel toxicity that is not typically seen with other anti-myeloma therapies.
$GSK https://twitter.com/DonnaYoungDC/status/1281581009755086850 -
DAX holder skansen.
-
DAX svagt stigende i samme tidsrum.
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind